These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24121273)

  • 1. Oncogenic suppression of PHLPP1 in human melanoma.
    Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
    Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.
    Yu Y; Dai M; Lu A; Yu E; Merlino G
    Oncogene; 2018 Apr; 37(17):2225-2236. PubMed ID: 29391600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.
    Ye Y; Jin L; Wilmott JS; Hu WL; Yosufi B; Thorne RF; Liu T; Rizos H; Yan XG; Dong L; Tay KH; Tseng HY; Guo ST; de Bock CE; Jiang CC; Wang CY; Wu M; Zhang LJ; Hersey P; Scolyer RA; Zhang XD
    Nat Commun; 2013; 4():1508. PubMed ID: 23443536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
    Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG
    Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
    Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
    Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors.
    Yan R; Chuang HC; Kapuriya N; Chou CC; Lai PT; Chang HW; Yang CN; Kulp SK; Chen CS
    J Med Chem; 2015 Mar; 58(5):2290-8. PubMed ID: 25689347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-mediated
    Peng M; Wang J; Tian Z; Zhang D; Jin H; Liu C; Xu J; Li J; Hua X; Xu J; Huang C; Huang C
    Autophagy; 2019 Sep; 15(9):1523-1538. PubMed ID: 30821592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop.
    Sinnberg T; Sauer B; Holm P; Spangler B; Kuphal S; Bosserhoff A; Schittek B
    Exp Dermatol; 2012 Apr; 21(4):265-70. PubMed ID: 22417301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
    Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
    Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
    Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
    Chern Y; Zhang P; Ju H; Tai IT
    Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
    [No Abstract]   [Full Text] [Related]  

  • 17. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.
    Liao WT; Li TT; Wang ZG; Wang SY; He MR; Ye YP; Qi L; Cui YM; Wu P; Jiao HL; Zhang C; Xie YJ; Wang JX; Ding YQ
    Clin Cancer Res; 2013 Sep; 19(17):4662-72. PubMed ID: 23846336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.
    Oy GF; Slipicevic A; Davidson B; Solberg Faye R; Maelandsmo GM; Flørenes VA
    Int J Cancer; 2010 Jan; 126(2):350-61. PubMed ID: 19588500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.
    Bradley EW; Carpio LR; Newton AC; Westendorf JJ
    J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.